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Summary
Neurodegeneration resulting in cognitive and motor impairment is an inevitable con-
sequence of aging. Little is known about the genetic regulation of this process
despite its overriding importance in normal aging. Here, we identify the Forkhead
Box O (FOXO) transcription factor 1, 3, and 4 isoforms as a guardian of neuronal
integrity by inhibiting age-progressive axonal degeneration in mammals. FOXO
expression progressively increased in aging human and mouse brains. The nervous
system-specific deletion of Foxo transcription factors in mice accelerates aging-
related axonal tract degeneration, which is followed by motor dysfunction. This
accelerated neurodegeneration is accompanied by levels of white matter astrogliosis
and microgliosis in middle-aged Foxo knockout mice that are typically only observed
in very old wild-type mice and other aged mammals, including humans. Mechanisti-
cally, axonal degeneration in nerve-specific Foxo knockout mice is associated with
elevated mTORC1 activity and accompanying proteotoxic stress due to decreased
Sestrin3 expression. Inhibition of mTORC1 by rapamycin treatment mimics FOXO
action and prevented axonal degeneration in Foxo knockout mice with accelerated
nervous system aging. Defining this central role for FOXO in neuroprotection during
mammalian aging offers an invaluable window into the aging process itself.
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1 | INTRODUCTION
The genetic regulation of aging in the nervous system and aging-
related neurodegenerative diseases remains one of the least under-
stood aspects of mammalian biology. In particular, axonal tract
degeneration is a common feature of neurodegenerative conditions
and aging-associated nervous system deterioration. Injury of the
brain or the spinal cord, inflammatory disorders, and age-related
degenerative conditions all share “axonopathy” despite varying eti-
ologies. However, the mechanism underlying the aging-related
axonopathy remains obscure, with important consequences for the
treatment of devastating diseases such as Alzheimer’s and Parkin-
son’s disease and amyotrophic lateral sclerosis.
Extensive evidence in invertebrate model organisms highlighted
the role of the FOXO transcription factor (DAF-16 in Caenorhabditis
elegans) in nervous system functions. DAF-16 regulates learning and
memory (Kauffman, Ashraf, Corces-Zimmerman, Landis & Murphy,
2010; Murakami, Bessinger, Hellmann & Murakami, 2005), axonal
degeneration and regeneration, and neurite outgrowth (Christensen,
de la Torre-Ubieta, Bonni & Colon-Ramos, 2011). The hyperactiva-
tion of DAF-16 in worm neurons is required for lifespan extension
following loss of insulin-like signaling (Wolkow, Kimura, Lee &
Ruvkun, 2000). This genetic study points to the potential importance
of FOXO in the nervous system as a central regulator of longevity.
Previous studies reported FOXO’s role in both neuroprotection
and neurodegeneration. The activation of the pro-survival phospho-
inositide-3 kinase (PI3K)–AKT pathway protected against neuronal
cell death in cases of nerve growth factor withdrawal, while the acti-
vation of FOXO in this context promoted cell death (Simon et al.,
2016). Neuroprotective NMDA receptor signaling by PI3K–AKT acti-
vation inhibited FOXO-dependent gene expression to suppress
oxidative stress in neurons (Papadia et al., 2008). Similarly, activation
of FOXO in mammalian neurons induced cell death (Gilley, Coffer &
Ham, 2003; Yuan et al., 2008, 2009). By contrast, constitutively
active FOXO protected neurons against excitotoxic and proteotoxic
insults (Mojsilovic-Petrovic et al., 2009).
Mechanistic target of rapamycin (mTOR) is a genetically and
pharmacologically proven regulator of aging and aging-related dis-
eases (Johnson, Rabinovitch & Kaeberlein, 2013). It is a master acti-
vator of cellular growth processes including protein and lipid
biosynthesis and a repressor of catabolic autophagy. Altered
mTORC1 signaling is associated with neurological and neurodevelop-
mental disorders, such as epilepsy, microcephaly, and autism. Aber-
rant activation of mTORC1 and its normalization by rapamycin have
been reported in studies on aging-associated conditions and diseases
such as Alzheimer’s (Caccamo, Majumder, Richardson, Strong &
Oddo, 2010; Spilman et al., 2010) and mouse models of laminopathy
(Ramos et al., 2012). These studies emphasized increased
proteotoxicity due to mTORC1 activation and insufficient autophagy
as a disease driving mechanism.
Here, we investigated the role of FOXO in mammalian central
nervous system aging both genetically and functionally. We hypothe-
sized that functionally redundant and developmentally dispensable
FOXO 1, 3, and 4 isoforms are necessary for healthy brain aging. To
investigate the role of FOXO 1, 3, and 4 transcription factors
together as broadly as possible in aging nervous system, we analyzed
mice with combined deletion of these FOXO genes in both neurons
and glia. We also tested whether loss of FOXO function in mature
neurons is sufficient to initiate aging-associated axonopathy. Func-
tional study on elevated mTORC1 in FOXO 1, 3, and 4 null brains
was performed to further prove their counteracting function in aging
brain. Our study broadly defines the neuroprotective role for FOXO
during aging and provides new insights into the function of FOXO in
the nervous system.
2 | RESULTS
2.1 | Expression of FOXO increases in aging brain
To date, there is no clear consensus on the expression of mam-
malian FOXO in aging tissues despite its evolutionarily conserved
role in longevity. We examined publically available datasets of
cohorts from studies on aging in the brain for information on
FOXO expression (Ramasamy et al., 2014). The expression of
FOXO1 significantly increased over the human lifespan in aged
(>60 year) brain tissues, while changes in FOXO3 or FOXO4
expressions were less pronounced or not observed at all across
different brain regions (Figure 1a,b and Table S1). An independent
analysis of FOXO1 and FOXO3 gene expressions in human cere-
bellums (Figure 1c,d) supported this finding. Expression of FOXO4
or FOXO6 in human cerebellums was low and did not significantly
change with age (Fig. S1a). This pattern was also observed in
aging mouse brains (Figure 1e,f) and the dataset from a study
analyzing multiple mouse strains for age-associated genes in the
cerebellum (Park et al., 2009) (Fig. S1b). We also examined AKT-
dependent phosphorylation of FOXO1/3 (T24/T32) status of
mouse age cohort samples. Overall, the levels of phosphorylated
FOXO1/3 did not correlate with age (Figure 1f). We measured
HBP1 a bona fide FOXO transcriptional target (Coomans de
Brachene et al., 2014) for its mRNA expression as readout of
FOXO activity. HBP1 mRNA was increased with aging tightly cor-
relating with FOXO expressions suggesting its activation (Fig. S1c).
From this analysis, we identified 651 genes positively correlating
with both increased FOXO1 expression and age across multiple
regions of human brain (Table S2). Analysis for transcription factor
binding site enrichment within the promoters of these genes
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F IGURE 1 Expression of FOXO increases in aging brain. (a) XY plots of FOXO1 or FOXO3mRNA expression within the noted brain regions vs.
age of the subjects at time of death. (b) Pearson correlation coefficients (r) and p-values for the correlation of FOXO1 or FOXO3mRNA expression in
various regions of the human brain with the age. (c) The mRNA expressions of FOXO1 and FOXO3were measured in human cerebellums (n = 33).
Blue and green dots indicate samples used forWB in (d). The mRNA (e) and protein (f) expression of Foxo1, Foxo3, and phospho-T24/32 Foxo1/3 in
young (<3-month, n = 6), adult (3-18-month, n = 6), and old (18–20-month, n = 6) FVB/B6mixed-strain mouse cerebellums is shown. Each dot
represents individual animal. Error bars, mean  SEM. *p < .05; **p < .01; ***p < .005. Statistical significance was determined by unpaired t-test. (g)
FOXO1 IHC analysis of brain sections ofWT and Foxo 1/3/4 KOmice. Residual FOXO1 immunoreactivity in KOmice is visible in endothelial cells
(inset). Scale bar = 200 lm. (h) RT-qPCR results for Foxo1 and Foxo3mRNA. Empty bars representWT, and colored bars represent KO tissues
(n = 4). (i) RepresentativeWestern blotting results. Foxo1- or Foxo1/3-specific knockouts (1KO or 1/3KO) selectively lost targeted isoforms. CBM—
cerebellum, STR—striatum, SCD—spinal cord, CTX—cortex, BST—brain stem, MDB—midbrain, HPC—hippocampus
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identified interferon regulatory factor (IRF, V$IRF3_06, IRF2_Q6, V
$IRF_Q6_01) as a potentially important regulator of these genes
(395 genes, p = 7e-05). Among the potential IRF-induced genes was
FOXO1 itself with predicted IRF3 binding sites within its proximal
promoter sequence. This suggests that FOXO1 expression as well
as its coregulated genes in the aging brain may be responding to
the inflammatory cytokines that are shown to progressively
increase with age in the brain (Bodles & Barger, 2004; Wilson,
Finch & Cohen, 2002). Indeed, the stimulation of primary neuronal
cultures with cytokines shown to increase in aging brains such as
interferons (IFN) or tumor necrosis factor (TNF)-a (Wilson et al.,
2002) induced the expression of both FOXO1 and FOXO3
(Fig. S2a). FOXO increased in both nuclear and cytoplasmic frac-
tions in the presence of cytokines (Fig. S2b,c). Furthermore, the
promoter regions of 174 of these genes contained the DAF-16
family binding element (DBE) FOXO motif, suggesting that they
may be direct FOXO targets. Previously reported FOXO targets
such as TXNIP (Webb, Kundaje & Brunet, 2016) and HBP1 (Coo-
mans de Brachene et al., 2014) were among these. In contrast to
the 651 genes positively correlating with both FOXO1 and age,
only 22 genes were found to be negatively correlated with both
FOXO1 and age across the same brain regions (Table S2). Tran-
scription factor binding site analysis yielded no significant results
on this set, and no genes with DBE motifs were identified. These
results show for the first time the coordinated expression of
FOXO and its putative targets in the aging mammalian brain as
well as the likely dependence of this increased expression on an
inflammatory milieu.
2.2 | Acceleration of aging-associated axonal tract
degeneration in Foxo1/3/4 knockout mice
To determine the role of FOXO upregulation in the nervous system
during aging, we employed conditional Foxo (FoxoL) alleles and
crossed them to human GFAP-cre, a transgenic mouse line with a
nervous system-specific deletion (Zhuo et al., 2001). Our approach
was to delete related FOXO 1, 3, and 4 isoforms given their func-
tional redundancy and their dispensability for neuro-development
(Paik et al., 2007, 2009). We did not include FOXO6 based on its
reported role in neocortex development and its low expression out-
side the hippocampus (Paap et al., 2016; Salih et al., 2012). To bet-
ter understand the ensuing phenotypes, we first determined the
deletion efficiency of FOXO1 and FOXO3, two major isoforms in
the brains of wild-type (WT) and Foxo 1/3/4 combined-knockout
(KO) animals. FOXO1 is highly expressed in layer-V cortical neu-
rons, the Bergman glia of the cerebellum, and the neurons of the
caudate putamen and dentate gyrus. This is consistent with the
in situ hybridization data from the Allen Brain Atlas
(RP_050407_02_B11) and the loss of immunoreactivity observed in
KO tissues (Figure 1g). Both the mRNA and protein expression pat-
terns (Figure 1h,i) indicate that FOXO3 is expressed throughout the
brain agreeing with the previous studies (Paik et al., 2009). Impor-
tantly, these animals did not show developmental abnormalities or
alterations in brain cytoarchitecture throughout early adulthood
(Paik et al., 2009). Instead, an immunohistochemical analysis of
astroglia (GFAP+) and microglia (Iba-1+) revealed extensive microglial
and astroglial activation in the white matter of the brains of adult
(10- to 15-month-old) KO mice, which was comparable to that
observed in aged (24- to 36-month-old) WT mice (Figure 2a–f and
Fig. S3a,b). In mice, rats, rhesus monkeys, and humans, an age-
related increase in white matter astrogliosis and microgliosis has
been extensively documented (Bronson, Lipman & Harrison, 1993;
Miller & Streit, 2007). Gliosis is likely caused by degenerative
changes in the axonal structure (Peters & Rosene, 2003). Indeed,
numerous microglia were found surrounding degenerating axons
(Figure 2d,e). Importantly, these changes are morphologically indis-
tinguishable from the axonal degeneration evident during aging in
aged WT animals (Fig. S3c) and occur at a considerably younger
age in KO mice (Figure 2f). Furthermore, Neurofilament H (NF-H)
staining showed that few intact axons were present with increasing
number of degenerating axons in the spinal cord lesion of KO mice
(Figure 2g,h), Importantly, Foxo 3/4 double knockout (3/4KO) ani-
mals did not exhibit above-described axonal degeneration nor reac-
tive microgliosis at advanced age excluding the possibility of cre
toxicity and further confirmed functional redundancy among FOXO
1, 3, and 4 isoforms (Fig. S4a,b). Furthermore, in agreement with
our histological findings, areas of microglial and astroglial activation
in the white matter also presented with extensive cavitation (Fig-
ure 2i, H&E); these cavities are most likely the result of degenerat-
ing axons and correspond to regions of T2-MRI hyperintense
lesions which typically result from a disorganized ultrastructure.
Together, our analysis showed that the effect of aging on the
microstructural integrity of the brain in KO mice is mainly white
matter degeneration, which is the most common and phylogeneti-
cally widespread aging-associated factor in nervous system
deterioration (Peters & Rosene, 2003).
F IGURE 2 Acceleration of aging-associated axonal tract degeneration in Foxo 1/3/4 knockout mice. Axonal tract degeneration and
associated reactive gliosis in brains and spinal cords are shown from adult mice as determined by GFAP (a), Iba-1 (c, d), or Neurofilament H
(NF-H) (g) IHC (n = 6–8). Quantitation of multiple IHC results is plotted (b, f, h). Error bars, mean  SEM. *p < .05; **p < .01; ***p < .005;
****p < .001. Statistical significance was determined by one-way ANOVA. (d) Activated phagocytic microglia (red arrow) wraps around cellular
debris from adult KO spinal cord. (e) Electron microscopy identified microglia (red arrow)-wrapped axonal remnants (green *). (g) Typical large
axons (green arrow) and dystrophic swollen and degenerating axons (red arrow) are shown from boxed areas. LF, lateral funiculus; VH, ventral
horn. (i) A close correspondence between cavitations in H&E sections and T2 MRI hyperintensity (red arrows). Scale bars = 200 lm (a, c, g, i)
and 2 lm (d, e)
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2.3 | A neuron-specific deletion of Foxo 1/3/4 is
sufficient to initiate axonal degeneration
To investigate the cause of degenerative phenotypes, we determined
whether axonal degeneration is due to cell-intrinsic defects by ana-
lyzing Synapsin 1 (Syn)-cre+;Foxo1/3/4L/L (KONeu) which exclusively
targets mature neurons because hGFAP-cre results in FOXO ablation
in both neurons and glial cells due to the activation in common pro-
genitors during early development (Zhuo et al., 2001). In KONeu mice,
the efficiency of Foxo deletion was overall poor with low penetrance,
with highest in neuron-rich brain regions (Figure 3a,b). Nevertheless,
white matter cavitation along with microglial and astroglial activation
was evident in the cerebellum of these mice starting at 6 months of
age (Figure 3c–e). We determined the axonal tract degeneration of
hippocampal commissure where microgliosis was readily visible with
Iba-1 IHC in adult KONeu mice (Figure 3f). Degenerated axon rem-
nants were colocalized with activated microglia in the lesion. These
degenerating white matter cavitations were also visible in T2-MRI
in vivo (Figure 3g). From these results, we conclude that the loss of
FOXO in neurons is sufficient to initiate aging-related axonal tract
degeneration.
To determine the functional consequence of axonal tract degen-
eration, we measured motor task performance. We examined
hGFAP-cre-mediated KO line because KONeu mice have very low pen-
etrance of cre expression affecting only a small fraction of mature
neurons. KO mice developed significant motor impairment at
advanced ages. Auditory startle reflexes, the voluntary wheel-run-
ning activity, baseline locomotor activity, and the motor coordination
dropped precipitously along with increased leg clasping behavior dur-
ing adulthood in KO mice (Figure 3h–l). These results corroborate
that FOXO confers and supports physiological health measures via
neuroprotection. Together, these results demonstrate that the loss
of FOXO accelerates axonal degeneration and ultimately leads to
motor dysfunction, a finding consistent with previous study in
C. elegans (Calixto, Jara & Court, 2012).
2.4 | Increased proteotoxic stress in Foxo 1/3/4
knockout neurons
To further probe the similarities between the neuropathological
changes in KO mice and those that occur during natural aging, we
compared changes in gene expression between the brains of chrono-
logically aged mice and adult KO mice. In a recent study of 12
mouse strains, 63 unique genes were commonly upregulated upon
aging in the brain (Park et al., 2009). Of these, Lzp-s, Gfap, C1qa,
C4B, and Ctss were established as having the most robust changes.
All of these genes were strongly induced in the axon-enriched stria-
tum of adult KO mice. This pattern was also found in aged mice rela-
tive to adult WT mice (Fig. S5a) suggesting that brains lacking FOXO
expression share core gene expression changes with chronologically
aged ones.
We further performed an integrated transcriptomic analysis of
laser capture microdissected dentate gyrus neurons to identify the
cellular processes that permit this accelerated aging. Dentate gyrus
neurons express high levels of FOXO proteins and showed highly
efficient deletion in KO mice (Figures 1g and 3a). Notably,
enriched processes by gene ontology analysis suggested an ongo-
ing elevation of protein aggregation and unfolding in KO neurons
(Fig. S5b). To validate these results, we analyzed brain cerebral
cortex lysates from old WT and KO animals for the presence of
proteotoxic stress. First, we detected significantly upregulated
expressions of molecular chaperone Hspb5 in both mRNA and
protein levels in multiple KO brain and spinal cord regions
(Fig. S6a,b) supporting the role of FOXO in controlling proteostasis
in the central nervous system. Furthermore, we found evidences
of proteotoxic stress in KO brains by measuring the accumulation
of ubiquitinated proteins, chaperone SQSTM1 (p62), and a selec-
tive autophagy cargo receptor neighbor of BRCA1 (NBR1). p62
and NBR1 bind to the ubiquitin (Ub) and microtubule-associated
protein 1 light chain 3 (LC3) to form protein aggregates: these are
degraded by autophagy and their accumulation reflects decreased
protein degradation and clearance capacity (Komatsu et al., 2007).
KO brains showed significantly increased steady-state levels of
p62, NBR1, and ubiquitinated proteins (Figure 4a,b), agreeing with
RNA expression profiling analysis suggesting the presence of pro-
teotoxic stress and compromised protein clearance (Fig. S5b). Con-
sistently, p62 and Ub immunolabeling on cortical neurons from
adult WT and KO brain cortex showed accumulation of labeling
positive inclusions (Figure 4c–e). In neurons, misfolded or aggre-
gated proteins are cleared by a coordinated chaperone-mediated
autophagy, macroautophagy, or Ub-proteasome system (Wong &
Cuervo, 2010). Ub-positive inclusions were noted in
autophagy-impaired Atg5-deficient neurons leading to degeneration
and motor dysfunction (Hara et al., 2006). We therefore posited
defective autophagy might play a causative role in proteotoxic
stress of KO neurons. However, not unexpectedly, brain cerebral
cortex lysates without lysosomal inhibition failed to show consis-
tent differences in LC3-I processing to LC3-II form (Figure 4a,b)
which is rapidly degraded by lysosomal hydrolysis. Instead, using
in vitro-differentiated neurons with a CRISPR-mediated knockdown
of individual FOXO isoforms, we determined the contribution of
FOXO1 and FOXO3 to the regulation of autophagic flux (Fig-
ure 4f,g). First, we introduced a dual fluorescent protein-tagged
DsRed-LC3-GFP reporter to quantitate autophagy activity (Sheen,
Zoncu, Kim & Sabatini, 2011). This reporter allows normalization
of autophagy activity measured as the decrease in GFP fluores-
cence to that in DsRed-LC3 fluorescence to calculate autophagy
index (see experimental procedures). FOXO deficiency profoundly
suppressed autophagy flux under basal condition while rapamycin,
an inducer of autophagy, treatment partially restored it (Figure 4h).
Consistently, both FOXO1 and FOXO3 knockdown cultures
showed reduced LC3-II levels when analyzed after treating cul-
tures with the lysosome inhibitor chloroquine (Figure 4i,j). Collec-
tively, our results support the notion that FOXO is necessary for
clearance of ubiquitinated proteins by increasing autophagic flux in
neurons.
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2.5 | Increased mTORC1 activity is due to loss of
SESN3 expression in Foxo1/3/4 knockout neurons
We further investigated the mechanistic basis of decreased autop-
hagy in KO neurons. Gene expression profiles indicated cellular pro-
cesses regulating growth and size might be significantly altered
(Fig. S5b). We hypothesized that KO neurons have hyperactivation
of mTORC1 signaling as it is the common regulator of cellular
growth as well as autophagy. This then leads to increased cap-
dependent protein translation and imbalanced inhibition of autop-
hagy-mediated protein degradation. Our findings support this
hypothesis: there was a profound elevation of S6K1 (Thr389) and
4EBP1 (Thr37/46) phosphorylation, reflecting activation of mTORC1
in KO brains (Figure 5a,b). Mechanistically, our survey of genes in
F IGURE 3 A neuron-specific deletion of Foxo 1/3/4 causes axonal degeneration. (a) FOXO1 IHC analysis of brains from mice with the
indicated genotypes. Corresponding boxed regions indicate the dentate gyrus and are shown in the lower panels. (b) RT-qPCR analysis of
Foxo1 and Foxo3 mRNA (n = 4). Colored bars represent KONeu tissues. (c) Indicated IHC analysis and H&E staining of cerebellums from adult
(15 mo) KONeu animals are shown. Arrows point to cavitations caused by degeneration. Scale bar = 200 lm. Quantitation of multiple IHC
results is shown for GFAP (d) or Iba-1 (e). Error bars, mean  SEM. ****p < .001. One-way ANOVA. (f) Iba-1 IHC analysis of the hippocampal
commissure from adult animals. Blue outline boxed region was further analyzed by co-IF of NF-H and Iba-1 in lower panels. Yellow arrow
points to degenerating axon remnant overlapping with microglia. Scale bars = 200 (IHC) and 20 (IF) lm. (g) T2-MRI of brains in adult mice with
the indicated genotypes. Arrows point to hyperintensity lesions. (h) Auditory startle reflexes and (i) the voluntary wheel-running activity. WT
(n = 7), KO (n = 5). (j) Rotarod motor coordination test, (k) hind leg clasping score, and (l) locomotor activity of 12-month-old WT (n = 9) and
KO (n = 5–9). Error bars, mean  SEM. *p < .05; **p < .01; ***p < .005. Statistical significance was determined by unpaired t-test
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F IGURE 4 Increased proteotoxic stress and defective autophagy in Foxo1/3/4 knockout mice. (a) Tissue lysates from 12-month-oldWT and KO
brain cortex were analyzed byWBof indicated proteins. (c) p62 IF and (d) p62 and Ub IHC on cortical neurons from 12-month-oldWT and KO brain
cortex. Red arrows point to labeling positive inclusions. Scale bar = 200 lm. (e) Quantitation of representative results for (d).
(f) Indicated genotype of neural progenitor cultures was differentiated into neurons for 5 days. Some cultures were treated with rapamycin (100 ng/ml)
for 24 hr on day 4 of differentiation. (h) The autophagy activity was analyzed by flow cytometry. The bar graph shows autophagy indices as % of control
of (f). (i) Cultures as in (f) were treated with chloroquine (100 ng/ml) for 4 hr and analyzed for the expression levels of LC3 byWB. Representative result
from three to five independent experiments is shown. (b, g, j) Quantitation ofWB band densities. Only chloroquine-treated cultures were statistically
compared in (j). Error bars, mean  SEM. *p < .05. **p < .01, ***p < .005; ****p < .001. Statistical significance was determined by one-way ANOVA
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mTORC1 pathway confirmed that SESN3 and RICTOR, bona fide
transcriptional targets of FOXO, were significantly downregulated in
KO brains (Figure 5a,b). Previous in vitro studies also support effec-
tor role of SESN3 and RICTOR in FOXO-regulated mTORC1 and
AKT activity, respectively (Chen et al., 2010). Indeed, reduction of
SESN3 expression was well correlated with increased phosphoryla-
tion of S6K1 and 4EBP1 in KO brains (Figure 5a,b). Consistently,
RICTOR-dependent mTORC2 activity was decreased as evidenced
by reduced phosphorylation of AKT (Ser473) in KO brains (Figure 5a,
b). We made similar observations in cultured cells: in vitro-differen-
tiated neuronal cultures with either FOXO1 or FOXO3 knockdown
exhibited elevated mTORC1 activity as shown by increased pS6K1
and reduced RICTOR expression (Figure 4f,g). Furthermore, enforc-
ing the expression of SESN3 in KO primary neurons was sufficient
to suppress elevated mTORC1 activity as shown by decreased pS6K
level (Figure 5c). These results together support the predicted action
of FOXO counteracting mTORC1 activity through its transcriptional
target SESN3 (Figure 5d).
2.6 | Inhibition of mTORC1 restores autophagy and
prevents axonal degeneration
Next, we determined whether proteotoxic stress and defective
autophagy could be corrected by normalizing mTORC1 activity in
KO brain and spinal cord. We did long-term (6 months) treatment of
rapamycin, a selective mTORC1 inhibitor. First, inhibition of
mTORC1 by rapamycin treatment was confirmed by the end point
analysis of decreased pS6K1 level. This inhibition appeared direct as
SESN3 expression remained significantly low in rapamycin-treated
KO brains (Figure 5e,f). The loss of S6K1 activity caused by
mTORC1 inhibition disrupts a negative feedback loop, resulting in
the reactivation of PI3K–AKT signaling. In agreement, we found that
rapamycin induced activation of AKT as evidenced by increased
phosphorylation by mTORC2 on Ser473 residue. Notably, the levels
of ubiquitinated proteins, p62, and NBR1 in rapamycin-treated KO
brains were normalized to the level of WT brains indicating
enhanced protein degradation and autophagy-mediated clearance.
We noted that LC3-II levels were largely increased in neuronal cul-
tures and rapamycin-treated animals suggesting its effectiveness in
increasing autophagic flux (Figures 4i,j and 5e,f). At the cellular level,
the frequency of cells with large p62 inclusions was decreased and
autophagolysosome formation was enhanced as evidenced by
increased lysosomal marker LAMP1 and p62 double-positive punctas
in neurons from rapamycin-treated KO animals (Fig. S7).
Our results show that defective clearance of protein inclusions
was the cause of increased HSPB5 expression. Rapamycin-treated
mice showed reduced expression of HSPB5 in the brain as well as in
the spinal cord (Figures 5e,f and 6a,b). This is consistent with the
hypothesis that defective autophagy contributes to the age-progres-
sive axonal degeneration as the level of Iba-1-positive reactive
microglia lesions in degenerating lateral thoracic columns was signifi-
cantly reduced in rapamycin-treated animals (Figure 6c,d). Further-
more, we determined whether reactive oxygen species (ROS) play a
role in driving axonal degeneration as a downstream mediator of
defective autophagy. Previously, we reported that FOXO-deficient
neural cells have elevated mitochondria content with increased
superoxide suggesting accumulation of defective mitochondria (Yeo
et al., 2013). We therefore tested whether the beneficial effect of
rapamycin could be explained by restoration of mitophagy and con-
sequential attenuation of ROS generation as previously discussed
(Scherz-Shouval & Elazar, 2011). Antioxidant N-acetylcysteine (NAC)
treatment of presymptomatic KO mice suppressed the age-progres-
sive axonal degeneration and reactive microglia lesions in the spinal
cord to a similar degree as rapamycin treatment (Figure 6e,f). Nota-
bly, NAC failed to prevent proteotoxicity as determined by HSPB5
expression (Figure 6g,h). These results suggest that ROS is likely to
be a downstream mediator of mTORC1 activation-induced autop-
hagy defect rather than being the cause. In agreement with the
improved pathology of the spinal cord, leg clasping behavior reflect-
ing neurodegenerative progression (Guyenet et al., 2010) was pre-
vented by both rapamycin and NAC treatments (Figure 6i,j).
Together, our findings support the conclusion that restoration of
autophagy capacity prevents age-progressive axonal degeneration
accelerated in Foxo 1/3/4 knockout mice by suppressing ROS as
illustrated in the Figure 6k model.
3 | DISCUSSION
Our findings reveal a pathway in which pro-inflammatory signals
affect neuronal integrity in the aging brain. Of note, neuroprotective
effects of pro-inflammatory cytokines have been reported while neu-
roinflammation itself was considered to be the signature pathology
of the aging brain. Based on our findings, pro-inflammatory signals
appear to be adaptive and neuroprotective by activating FOXO, but
this does not preclude them from being a driver of the aging pro-
cess. Activation of FOXO may counteract what would otherwise be
a trigger for age-dependent degeneration (i.e., hyperactive mTORC1).
In agreement, innate immune responses to tissue damages (a.k.a.
sterile inflammation) were shown to activate FOXO in an inverte-
brate model (Obata et al., 2014). It is plausible that axonal degenera-
tion due to loss of proteostasis or FOXO function during aging
initiates reactive gliosis to prevent further neuronal damage. This
activates pro-inflammatory signal for the feed-forward increase of
FOXO expression to quell the cause of damage in neurons. Loss of
neuronal FOXO function would therefore exacerbate inflammatory
responses in aging brain, thus corroborating our findings from the
mouse model. Consistently, we observed accumulation of FOXO in
the nucleus as well as in the cytoplasm following 48-h treatment
with TNF-a and IFN-b in primary neurons (Fig. S2b,c). Collectively,
these observations support the notion that timely regulation of
FOXO at the level of both expression and activity is necessary for
its neuroprotective effect under pro-inflammatory signals. In line
with our model, IFN-b protects against spontaneous accumulation of
protein aggregates in neurons. Lack of IFN-b signaling led to defects
in neuronal autophagy which caused spontaneous neurodegeneration
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F IGURE 5 Inhibition of aberrant mTORC1 activation suppresses proteotoxic stress in Foxo 1/3/4 knockout mice. (a) Tissue lysates from 12-
month-old WT and KO brain cortex were analyzed by WB of indicated proteins. (c) Representative WB of primary neuronal cultures from WT
and KO animals infected with indicated retroviral particles. (d) A summary of FOXO and mTORC1 crosstalk leading to the counterbalancing or
proteotoxicity. (e) Tissue lysates from 12-month-old either rapamycin-treated or not, WT and KO brain cortex were analyzed by WB of
indicated proteins. (b, c, f) Quantitation of WB band intensities. *p < .05; **p < .01; ***p < .005; ****p < .001. Statistical significance was
determined by one-way ANOVA
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associated with a-synucleinopathy (Ejlerskov et al., 2015). Whether
FOXO plays any roles in cytokine-induced autophagy warrants
further investigation.
Our study demonstrated that depletion of neuronal FOXO 1, 3,
and 4 is sufficient to initiate degeneration and to advance aging phe-
notypes in the brain. However, we do not exclude the possibility
that FOXO expression in glial cells is necessary for maintaining white
matter integrity in aging animals as its knockout in both neuron and
glial cells results in earlier and more profound degenerative pheno-
types. Whether the degree of phenotypic severity resulting from
employing multiple cre drivers depends solely on different
penetrance remains to be determined.
Importantly, we did not observe any apparently degenerating cell
bodies or apoptotic cells in the cortical, hippocampal, or cerebellar
neurons of KO or WT mice, even at advanced ages, despite exten-
sive axonal tract degeneration. Also, there was no degeneration in
lower motor neurons, grouped atrophy of muscle fibers, or reduction
in dopaminergic neurons (not shown), distinguishing age-progressive
axonopathy phenotype from those of other neurodegenerative dis-
eases with different etiologies. Our data agree with the recent para-
digm shift in the understanding of brain aging: the loss of cell bodies
is considerably rarer than was once thought, and instead, the major
aging-related changes occur in the white matter (Morrison & Hof,
1997; Peters & Rosene, 2003). Furthermore, the mechanism underly-
ing this aging-related “dying-back” of distal axons over an extended
period has not been clearly understood. In this regard, our study
reports FOXO functions to suppress the common neuropathology of
chronological aging in mammals: the acceleration of axonal tract
degeneration, which is an aging-related pathology that has been
reported in rodents, dogs, and primates (Peters & Rosene, 2003).
This may in turn contribute to sarcopenia, peripheral sensory loss,
and impaired motor and cognitive function during aging.
Functional and genetic analyses of mTORC1 and FOXO in
worms showed both epistatic and parallel interactions in regulating
lifespan. Inhibition of mTORC1 and its downstream effector S6K
does not require FOXO (Hansen et al., 2007; Pan et al., 2007) while
rapamycin-induced longevity depends on FOXO (Robida-Stubbs
et al., 2012). These studies support the notion that mTORC1 regu-
lates aging by mechanisms that both overlap and distinct from
FOXO. Our results that FOXO counteracts mTORC1-dependent ana-
bolic activity and promotes autophagy activity through its target
genes agree with previous studies in other cell types (Webb & Bru-
net, 2014). Loss of this balance through favoring mTORC1 activation
over decreased autophagy by inactivation of FOXO may result in
chronic stress and insults to aging neurons. This is highly likely as
the inhibition of basal autophagy in the nervous system is sufficient
to cause neurodegeneration in mice (Hara et al., 2006). In our exper-
imental model of accelerated brain aging, mTORC1 hyperactivation
impairs effective clearance protein aggregates and damaged orga-
nelles that contribute to age-progressive axonal degeneration (Fig-
ure 6k). However, it is worth to note that mTORC1 activity may not
necessarily increase to contribute to age-progressive axonopathy.
Instead, aging neurons may rely more on autophagy due to
decreased neurotrophic factors and impaired nutrient uptake as pre-
viously reported in aging hematopoietic cells (Warr et al., 2013).
Increased FOXO expression in aging brain may also reflect increased
demand on autophagy explaining the beneficial effect of rapamycin.
Interestingly, our result also showed that rapamycin upregulates the
expression of FOXO proteins in both brain tissue and neuronal cul-
tures (Figure 4f,g and 5e,f). This observation suggests a potential
hierarchy of mTORC1 and FOXO regulatory pathways. In addition,
mTORC1 inhibition by rapamycin partially restored autophagy in a
FOXO knockdown background and suppressed proteotoxic stress in
KO brain. These results indicate that rapamycin may also work in
parallel to or downstream of FOXO action in regulating autophagy.
As a result, rapamycin mimics FOXO activation by increasing autop-
hagic flux even in the absence of FOXO.
The upregulation of HSPB5 expression in aging-related acceler-
ated axonal degeneration in KO neurons is mechanistically informa-
tive. While a loss of proteostasis and induction of HSPB5 are
signature changes of Foxo-deficient neurons, it is notable that NAC
treatment partially prevented the degeneration of KO animals with-
out improving proteostasis (Figure 6g,h). This observation supports
the outweighing role of ROS in driving degeneration. These bio-
chemical changes may represent promising points of intervention in
the aging brain. Lastly, the Foxo knockout mice may also provide a
neurodegenerative disease-independent model that can be leveraged
in the development of therapies to combat age-related neurodegen-
eration.
4 | EXPERIMENTAL PROCEDURES
4.1 | Generation of experimental mouse cohorts
Nervous system-specific Foxo knockout was generated by crossing
floxed Foxo mice (Paik et al., 2009) to hGFAP-cre mice. Neuron-spe-
cific Synapsin1-cre; Foxo1/3/4L/L mice in B6 background were kindly
provided by Dr. Domenico Accili (Columbia University, NY). Mice
were on a mixed background of FVB and B6 if not otherwise indi-
cated. The resulting offsprings were intercrossed to generate mice of
the desired genotypes. All animal experiments were approved by
Institutional Animal Care and Use Committee. Roughly 1:1 ratio of
male and female mice was used for behavioral, imaging, biochemical,
and metabolite analyses. For rapamycin or NAC-feeding experiment,
animals were assigned to experimental groups arbitrarily according
to age, gender, and genotype without formal randomization. All the
animal experiments were repeated multiple times to ensure repro-
ducibility. Animals that show unusual health condition (i.e., runted,
rectal prolapse) were excluded from further analysis.
4.2 | Magnetic resonance imaging
MRI of the brain was performed on a 7 T animal MRI scanner (Bru-
ker, Billerica, MA, USA) with a dedicated mouse head coil. Coronal
T2-weighted images were obtained using the rapid-acquisition relax-
ation-enhanced (RARE) sequence: TR = 3,500 ms, TE = 75 ms,
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twelve repetitions were acquired and averaged, acquisition time
11 min and 12 s, matrix size 256 9 256, field of view 2.5 9 2.5 cm,
slice thickness 0.5 cm, 16 sections acquired. Axial T2-weighted MRI
of the spinal cord was performed using the same RARE sequence
except a mouse body coil was used. Representative images from
more than 10 animals per genotype analyzed are presented.
4.3 | Aging brain expression analysis
A gene expression dataset of 134 postmortem human brains dis-
sected into 10 regions was used to assess FOXO1, FOXO3, and
FOXO4 expression in relation to subject age at time of death
(Ramasamy et al., 2014) (GEO ID: GSE60863). Probe set for
FOXO6 was not available. The Affymetrix exon array data were
normalized with the Affymetrix RMA sketch algorithm in probe-
level mode and loaded into R2: Genomics Analysis and Visualiza-
tion Platform (http://r2.amc.nl) for further analysis. For Figure 1a,b,
probes 3510861 (FOXO1) or 3748564 (FOXO3) (log2 normalized)
were used. The p-values provided are FDR-corrected based on an
analysis of all genes correlated with age within each brain region.
For validation of FOXO expression pattern in aging human brains,
33 cerebellums de-identified and provided by NIH brain biobank
were analyzed by RT-qPCR as below. Mouse gene expression array
data from a published study (Park et al., 2009) were analyzed for
FOXO expressions comparing 5-month vs. 25-month-old mice
(n = 5). For validation, cerebellums from 1.5- to 20-month-old
FVB/B6 mice were analyzed. For gene expression analysis of WT
vs. KO dentate gyrus, laser capture microscopy was performed at
Harvard NeuroDiscovery Advanced Tissue Resource Center and
analyzed by microarray MOE (430 2.0). CEL files were prepro-
cessed by RMA. The background-corrected, normalized, and sum-
marized probe set intensity data were then analyzed using
significance analysis of microarrays (SAM) to identify differentially
expressed genes. Using a twofold, FDR 5% cutoff, we generated a
set of 415 probe that distinguishes differentially expressed genes
in WT vs. KO. Differentially expressed gene list was further ana-
lyzed by the DAVID Gene Ontology analysis. Dataset GSE102137
is available at (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE102137).
4.4 | Rapamycin or NAC feeding
Both WT and KO animals at 6 months of age were treated for
24 weeks. LabDiet 5LG6 with 42 ppm encapsulated rapamycin
diets was fed ad libitum. NAC (Sigma) was administered by dissolving
in drinking water (40 mM, ad libitum) as previously described (Yeo
et al., 2013). Water was replaced weekly.
4.5 | Assessment of sensorimotor function
We determined the time of paresis onset and the rate of progression
for all animals by biweekly assessment of hindlimb clasping according
to Guyenet, et al. (Guyenet et al., 2010). Briefly, if the hindlimbs are
splayed outward, away from the midline, it is assigned a score of 0. If
one hindlimb is retracted to the abdomen for more than 50% of the
time suspended, it receives a score of 1. If both hindlimbs are partially
retracted toward the abdomen for more than 50% of the time sus-
pended, it receives a score of 2. If its hindlimbs are entirely retracted
and touching the abdomen for more than 50% of the time suspended,
it receives a score of 3. The paresis progresses to full paralysis, ulti-
mately necessitating humane sacrifice. The age of IACUC-mandated
sacrifice of mice was plotted as paresis-free survival curve. For motor
coordination and balance, we used the rotarod performance test. Sub-
jects were given three training trials to learn to walk on a rotating
beam prior to the actual test. Rotarod treadmill (version 8, IITC Life-
science, Woodland Hills, CA) was used with 4–45 rpm acceleration
over 2 min. For acoustic startle reflex test, mice were placed in an SR-
pilot startle reflex apparatus (San Diego Instruments, San Diego, CA).
Background noise was 65 dB. After a 5-min habituation period, startle
stimuli (115 dB) were presented and responses were recorded. For
voluntary wheel-running activity, total distance from individually
housed mice over a week period was recorded. Locomotor activity
was evaluated in an open field (45 9 45 cm). The total distance
moved was recorded every 10 min for 120 min using a video tracking
system (Ethovision 3.0, Noldus Technology). Neurological scoring and
motor function measurements were performed by an independent
researcher blinded to the experimental conditions.
4.6 | Immunohistochemistry (IHC) and
immunofluorescence (IF)
Formalin-fixed, paraffin-embedded 5-micrometer sections were used.
For stains of brain, sections were processed in standard method and
incubated with primary antibodies to rabbit anti-FOXO1 (1:100,
#2880, Cell signaling technology) and rabbit anti-Iba1 (1:500, #019-
19741,Wako), rabbit anti-GFAP (1:400, #Z0334, DAKO), mouse anti-
Neurofilament H (1:1,000, clone SMI32, Millipore), mouse anti-
HSPB5 (10 lg/ml, Clone1B6.1-3G4, Stressgen), mouse anti-p62
(1 lg/ml, #56416, Abcam), rat anti-LAMP1 (10 lg/ml, #25245),
mouse anti-Ubiquitin (1: 300, #3936, Cell signaling technology) anti-
bodies and further processed by Vector Elite ABC peroxidase kit fol-
lowed by developing with DAB or NovaRED substrate and
counterstained with hematoxylin. Transverse sections of the spinal
cord were treated with a permeabilization/blocking solution contain-
ing 10% FCS, 2% bovine serum albumin, 1% glycine, and 0.05%
F IGURE 6 Restoring autophagy and reducing ROS prevent axonal degeneration. HSPB5 (a, g) or Iba-1 (c, e, upper panels) IHC and NF-H/Iba-
1 co-IF (c, e, lower panels) analysis of transverse sections of the thoracic spinal cord (n = 8–10). Representative lesions in the lateral funiculi from
animals treated for 24 weeks from 6 months of age are shown. (b, d, f, h) quantitation of IHC results. Scale bars = 200 lm. Hind leg clasping
score of 12-month-oldWT and KO mice with or without rapamycin (n = 10–12) (i) or NAC (n = 12–17) (j) treatment. Error bars, mean  SEM.
*p < .05; **p < .01; ***p < .005; ****p < .001. Statistical significance was determined by one-way ANOVA. (k) A schematic summary
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Triton X-100. Primary antibodies were diluted in PBS containing
0.05% Triton X-100, 0.1% Tween-20, and 2% horse serum and
applied for 1 hr in a humidified chamber at room temperature. For
IF of FOXO in cultured primary neurons, cells were fixed in 3.7%
paraformaldehyde and permeabilized with 0.2% Triton X-100. Pri-
mary antibodies were added in 3% BSA/PBS and incubated over-
night at 4 degrees followed by Alexa Fluor 488-conjugated donkey
anti-rabbit (1:1,000; #A21206, Thermo Fisher) secondary antibody
labeling.
4.7 | RT-qPCR analysis
RNA was harvested using GeneJET RNA purification kit (Fermentas)
and treated with RQ1 RNase-free DNase (Promega). Then, one
microgram of total RNA was reverse-transcribed into cDNA utilizing
Maxima first-strand cDNA synthesis kit for RT-qPCR (Fermentas).
PCR was performed on cDNA samples using the Power SYBR
Green Master mix (Applied Biosystems) and was performed the PCR
on the StepOnePlusTM Real Time PCR System (Applied Biosystems).
Primer sequences are as below. Each sample was run as duplicates
(triplicates), and the mRNA level of each sample was normalized to
that of the 18s mRNA. The relative mRNA level was presented as



















4.8 | Western blot analysis
Cells or tissues were directly lysed in Laemli SDS sample buffer, and
protein concentration was determined by DC Protein Assay Reagents
(Bio-Rad). Immunoblots were performed with the following antibodies:
FOXO1 (#2880, 1:1,000), phospho-FOXO1 (Thr24)/FOXO3 (Thr32)
(#9464, 1:1,000), phospho-S6 (#4858, 1:2,000), S6 (#2317, 1:2,000),
phospho-S6K1 (#9234, 1:1,000), S6K1 (#2708, 1:2,000), phosphor-
AKT (#4060, 1:2,000), AKT (#9272, 1:5,000), phospho-4EBP1 (#2855,
1:1,000), 4EBP1 (#9644, 1:2,000), Ubiquitin (#3936, 1:3,000), Rictor
(#2114,1:1,000), LC3A/B (#12741, 1:3,000), NBR1 (#9891, 1:1,000),
HSPB5 (#8851, 1:1,000) from Cell Signaling Technology, FOXO3
(#NB100-614, 1:2,000, Novus), b-actin (#A5316, 1:5,000, Sigma), p62
(#ab65416, 1:5,000, Abcam), V5 (# ab27671, 1:5,000), and Sestrin3
(#H00143686-M02, 1:1,000, Abnova).
4.9 | Autophagy analysis in cultures
To measure autophagic activity by flow cytometric analysis, we used
a dual-color autophagy reporter DsRed-LC3-GFP (Sheen et al., 2011).
pQCXI Puro DsRed-LC3-GFP (Addgene # 31182) was used to gener-
ate retroviral particles to infect mouse neural progenitors. Cells were
subsequently differentiated in B27 containing N2 media for 5 days
prior to the analysis. The autophagy index was calculated with the
formula: 100 – (100 9 (FL1/FL2)) for measuring relative change in
GFP to DsRed. The FL1 is the median fluorescence intensity of GFP
fluorescence, and FL2 is the median fluorescence intensity of DsRed
fluorescence. FOXO knockdown mouse neural progenitors were gen-
erated by infecting immortalized Ink/Arf null postnatal mouse neural
progenitors with lenti-CRISPR vectors with a specific sgRNA: FOXO1,
CGACAGCGGCCCGGTCGGTG; FOXO3, GCGGGTGATCAGGTCGG-
CAT; CON (Scr), GCACTACCAGAGCTAACTCA or Addgene # 51764.
4.10 | Statistical analysis
We determined experimental sample sizes on the basis of prelimi-
nary data. The size of experimental groups and statistical test applied
are indicated in the figure legends. All results are expressed as
mean  SEM. GraphPad Prism software (version 7, San Diego, CA)
was used for all statistical analysis. Normal distribution of the sample
sets was determined before applying unpaired Student’s two-tailed
t-test for two group comparisons. One-way ANOVA was used to
assess the differences between multiple groups. The mean values of
each group were compared by the Bonferroni’s post hoc procedure.
Differences were considered significant when p < .05.
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